Track the 지에프씨생명과학 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 지에프씨생명과학 has recorded 33 public disclosures. Market capitalisation: €33.5bn. The latest transaction was disclosed on 22 May 2026 (Other). Among the most active insiders: 강희철. The full history is openly available.
33
Insider Decl.
0
Thresholds
€2m
14 ops.
Buy Volume
·
3 ops.
Sell Volume
22Σ signal
Buys €2m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,106 of 26,212 companies
36.3
score / 100
Value
28
Quality
45
FCF yld-23%
Earn yld2.0%
EV/EBITDA16.7x
ROE4.1%
Gross mgn48%
Net mgn3.1%
Debt/EBITDA3.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.